Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Cellectis S.A. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −5 vs. Q2 2023
- Shares held
- 11.5M
- −2.53M (−18.0%) vs. Q2 2023
- Total value
- $18.1M
- −$9.45M (−34.3%) vs. Q2 2023
- New holders
- 2
- 8 more added
- Sold out
- 7
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7.09M | 1.02% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $2.92M | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 1,438,255 | $2.27M | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 1,164,009 | $1.84M | 0.00% | −254,987−18.0% | Reduced |
| Millennium Management LLC | 1,095,966 | $1.73M | 0.00% | −71,675−6.1% | Reduced |
| Principal Financial Group Inc | 656,600 | $1.04M | 0.00% | −10,441−1.6% | Reduced |
| Macquarie Group Ltd | 226,875 | $358.0K | 0.00% | 00.0% | Unchanged |
| KBC Group NV | 163,447 | $258.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 121,420 | $191.8K | 0.00% | +3,731+3.2% | Added |
| Morgan Stanley | 67,592 | $106.8K | 0.00% | −9,560−12.4% | Reduced |
| LPL Financial LLC | 63,657 | $100.6K | 0.00% | +49,650+354.5% | Added |
| D. E. Shaw & Co., Inc. | 47,154 | $74.5K | 0.00% | −31,675−40.2% | Reduced |
| Citadel Advisors LLC | 34,300 | $54.2K | 0.00% | +4,317+14.4% | Added |
| Wells Fargo & Company | 15,544 | $24.6K | 0.00% | −375−2.4% | Reduced |
| BNP Paribas Arbitrage, SA | 10,944 | $17.3K | 0.00% | +9,727+799.3% | Added |
| Geode Capital Management, LLC | 10,776 | $17.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,970 | $14.2K | 0.00% | +3,605+67.2% | Added |
| JPMorgan Chase & Co | 5,023 | $7.94K | 0.00% | +4,504+867.8% | Added |
| UBS Group AG | 4,035 | $6.38K | 0.00% | +4,035 | New |
| National Bank of Canada | 3,600 | $5.35K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,970 | $4.69K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,755 | $4.35K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 360 | $540 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% | +66+146.7% | Added |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% | +40 | New |
| Toronto Dominion Bank | 31 | $49 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 28 | $44 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 10 | $10 | 0.00% | +8+400.0% | Added |
| Bank of America Corp | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 56 | $0 | 0.00% | 00.0% | Unchanged |
| Bpifrance SA | 0 | $0 | 0.00% | −2,186,960−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −27,841−100.0% | Sold out |
| One68 Global Capital, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −2,721−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −48−100.0% | Sold out |